Diabetic individuals face a significantly higher risk (\(\sim\)56%) of developing MASLD compared to non-diabetics, and it has been found that 70%90% of MASLD patients also have DM or insulin resistance [4, 5]
For this natural protective shield to work properly, it must be in its active form, as it is only capable of directly intervening in your bodys processes in this state [2]
In contrast, the immune system can detect pathogens more easily than cancerous cells because they are foreign, resulting in a more robust immune response [15]
This also raises an unresolved question as to whether GSH efflux serves primarily as a permissive biochemical event or represents an actively regulated signaling step in apoptotic commitment
Zhao Y, Haney MJ, Jin YS, Uvarov O, Vinod N, Lee YZ, Langworthy B, Fine JP, Rodriguez M, El-Hage N, Kabanov AV, Batrakova EV